- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
CA.2: 5 residues within 4Å:- Chain A: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.367, A:R.514, A:S.533, A:E.535, A:S.600
CA.3: 5 residues within 4Å:- Chain A: Q.889, D.892, D.895, D.897
- Chain D: N.449
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:Q.889, A:D.892, A:D.895, A:D.897, A:D.897
CA.15: 5 residues within 4Å:- Chain B: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:D.367, B:R.514, B:S.533, B:E.535, B:S.600
CA.16: 5 residues within 4Å:- Chain A: N.449
- Chain B: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:Q.889, B:D.892, B:D.895, B:D.897, B:D.897
CA.26: 5 residues within 4Å:- Chain C: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.367, C:R.514, C:S.533, C:E.535, C:S.600
CA.27: 5 residues within 4Å:- Chain B: N.449
- Chain C: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:Q.889, C:D.892, C:D.895, C:D.897, C:D.897
CA.35: 5 residues within 4Å:- Chain D: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.367, D:R.514, D:S.533, D:E.535, D:S.600
CA.36: 5 residues within 4Å:- Chain C: N.449
- Chain D: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:Q.889, D:D.892, D:D.895, D:D.897, D:D.897
- 20 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.4: 3 residues within 4Å:- Chain A: I.241, F.252, F.303
Ligand excluded by PLIPPOV.10: 11 residues within 4Å:- Chain A: T.273, W.275, E.276, V.278, Y.279
- Chain D: T.298, R.301, L.302
- Chain H: F.62, I.63, C.67
Ligand excluded by PLIPPOV.11: 11 residues within 4Å:- Chain A: A.121, G.125, V.128, I.132, N.136, D.147, F.148, T.149
- Chain H: G.65, L.69, L.73
Ligand excluded by PLIPPOV.12: 10 residues within 4Å:- Chain A: I.226, L.227, K.228, T.229, S.232, L.235, V.236, S.240, I.243
- Ligands: POV.47
Ligand excluded by PLIPPOV.13: 10 residues within 4Å:- Chain A: T.298, R.301, L.302
- Chain B: T.273, W.275, E.276, V.278, Y.279
- Chain E: F.62, C.67
Ligand excluded by PLIPPOV.17: 3 residues within 4Å:- Chain B: I.241, F.252, F.303
Ligand excluded by PLIPPOV.21: 11 residues within 4Å:- Chain B: A.121, G.125, V.128, I.132, N.136, D.147, F.148, T.149
- Chain E: G.65, L.69, L.73
Ligand excluded by PLIPPOV.22: 10 residues within 4Å:- Chain B: I.226, L.227, K.228, T.229, S.232, L.235, V.236, S.240, I.243
- Ligands: POV.44
Ligand excluded by PLIPPOV.23: 9 residues within 4Å:- Chain B: T.298, R.301, L.302
- Chain C: T.273, W.275, E.276, V.278, Y.279
- Chain F: C.67
Ligand excluded by PLIPPOV.28: 3 residues within 4Å:- Chain C: I.241, F.252, F.303
Ligand excluded by PLIPPOV.32: 11 residues within 4Å:- Chain C: A.121, G.125, V.128, I.132, N.136, D.147, F.148, T.149
- Chain F: G.65, L.69, L.73
Ligand excluded by PLIPPOV.33: 10 residues within 4Å:- Chain C: I.226, L.227, K.228, T.229, S.232, L.235, V.236, S.240, I.243
- Ligands: POV.45
Ligand excluded by PLIPPOV.37: 4 residues within 4Å:- Chain A: K.331
- Chain D: I.241, F.252, F.303
Ligand excluded by PLIPPOV.41: 9 residues within 4Å:- Chain C: T.298, R.301, L.302
- Chain D: T.273, W.275, E.276, V.278, Y.279
- Chain G: C.67
Ligand excluded by PLIPPOV.42: 10 residues within 4Å:- Chain D: A.121, G.125, V.128, I.132, N.136, D.147, F.148, T.149
- Chain G: G.65, L.73
Ligand excluded by PLIPPOV.43: 10 residues within 4Å:- Chain D: I.226, L.227, K.228, T.229, S.232, L.235, V.236, S.240, I.243
- Ligands: POV.46
Ligand excluded by PLIPPOV.44: 6 residues within 4Å:- Chain B: I.326, R.329
- Chain E: L.51, F.52, I.55
- Ligands: POV.22
Ligand excluded by PLIPPOV.45: 5 residues within 4Å:- Chain C: I.326, R.329
- Chain F: L.51, I.55
- Ligands: POV.33
Ligand excluded by PLIPPOV.46: 5 residues within 4Å:- Chain D: I.326, R.329
- Chain G: L.51, I.55
- Ligands: POV.43
Ligand excluded by PLIPPOV.47: 6 residues within 4Å:- Chain A: I.326, R.329
- Chain H: L.51, F.52, I.55
- Ligands: POV.12
Ligand excluded by PLIP- 11 x CLR: CHOLESTEROL(Non-covalent)
CLR.5: 5 residues within 4Å:- Chain A: I.39, I.40, W.43, K.174, W.178
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:I.40, A:W.43, A:W.43, A:W.43, A:W.178, A:W.178
CLR.6: 5 residues within 4Å:- Chain A: W.23, A.24, S.28, V.31, T.32
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.23, A:V.31
CLR.18: 3 residues within 4Å:- Chain B: S.96, V.97, W.100
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:W.100, B:W.100, B:W.100, B:W.100
CLR.19: 7 residues within 4Å:- Chain B: I.39, W.43, R.44, F.168, K.174, W.178
- Chain F: L.39
5 PLIP interactions:1 interactions with chain F, 4 interactions with chain B- Hydrophobic interactions: F:L.39, B:W.43, B:W.43, B:F.168, B:W.178
CLR.20: 9 residues within 4Å:- Chain B: M.21, W.23, A.24, S.28, V.31, T.32, V.195, Y.198, L.199
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:W.23, B:W.23, B:V.31, B:V.195, B:Y.198, B:L.199, B:L.199
CLR.29: 3 residues within 4Å:- Chain C: S.96, V.97, W.100
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:V.97, C:W.100, C:W.100, C:W.100, C:W.100, C:W.100, C:W.100
CLR.30: 6 residues within 4Å:- Chain C: I.39, W.43, R.44, F.168, K.174, W.178
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:W.43, C:W.43, C:F.168, C:W.178
CLR.31: 9 residues within 4Å:- Chain C: M.21, W.23, A.24, S.28, V.31, T.32, V.195, Y.198, L.199
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:W.23, C:W.23, C:V.31, C:V.195, C:Y.198, C:L.199, C:L.199
CLR.38: 4 residues within 4Å:- Chain D: S.96, V.97, W.100, I.169
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:V.97, D:W.100, D:W.100, D:W.100, D:W.100, D:W.100, D:I.169
CLR.39: 8 residues within 4Å:- Chain D: I.39, I.40, W.43, R.44, F.168, K.174, W.178
- Chain H: L.39
7 PLIP interactions:6 interactions with chain D, 1 interactions with chain H- Hydrophobic interactions: D:I.40, D:W.43, D:F.168, D:K.174, D:W.178, D:W.178, H:L.39
CLR.40: 9 residues within 4Å:- Chain D: M.21, W.23, A.24, S.28, V.31, T.32, V.195, Y.198, L.199
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:W.23, D:W.23, D:V.31, D:V.195, D:Y.198, D:L.199, D:L.199
- 4 x K: POTASSIUM ION(Non-covalent)
K.7: 9 residues within 4Å:- Chain A: G.289, Y.290
- Chain B: G.289, Y.290
- Chain C: G.289, Y.290
- Chain D: G.289, Y.290
- Ligands: K.8
3 PLIP interactions:1 interactions with chain C, 1 interactions with chain B, 1 interactions with chain A- Metal complexes: C:G.289, B:G.289, A:G.289
K.8: 10 residues within 4Å:- Chain A: V.288, G.289
- Chain B: V.288, G.289
- Chain C: V.288, G.289
- Chain D: V.288, G.289
- Ligands: K.7, K.24
5 PLIP interactions:1 interactions with chain A, 1 interactions with chain D, 1 interactions with chain B, 2 interactions with chain C- Metal complexes: A:V.288, D:V.288, B:V.288, C:V.288, C:G.289
K.9: 5 residues within 4Å:- Chain A: T.287
- Chain B: T.287
- Chain C: T.287
- Chain D: T.287
- Ligands: K.24
4 PLIP interactions:1 interactions with chain D, 1 interactions with chain C, 1 interactions with chain A, 1 interactions with chain B- Metal complexes: D:T.287, C:T.287, A:T.287, B:T.287
K.24: 10 residues within 4Å:- Chain A: T.287, V.288
- Chain B: T.287, V.288
- Chain C: T.287, V.288
- Chain D: T.287, V.288
- Ligands: K.8, K.9
5 PLIP interactions:2 interactions with chain C, 1 interactions with chain D, 2 interactions with chain B- Metal complexes: C:T.287, C:V.288, D:V.288, B:T.287, B:V.288
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Agarwal, S. et al., Ball-and-chain inactivation of a human large conductance calcium-activated potassium channel. Nat Commun (2025)
- Release Date
- 2025-03-05
- Peptides
- Isoform 5 of Calcium-activated potassium channel subunit alpha-1: ABCD
Large-conductance Ca2+-activated K+ channel beta2 subunit,Calcium-activated potassium channel subunit beta-4: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
- 20 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 11 x CLR: CHOLESTEROL(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Agarwal, S. et al., Ball-and-chain inactivation of a human large conductance calcium-activated potassium channel. Nat Commun (2025)
- Release Date
- 2025-03-05
- Peptides
- Isoform 5 of Calcium-activated potassium channel subunit alpha-1: ABCD
Large-conductance Ca2+-activated K+ channel beta2 subunit,Calcium-activated potassium channel subunit beta-4: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H - Membrane
-
We predict this structure to be a membrane protein.